Abbott Vascular (ABT) Receives CE Mark for World's Longest Coronary Drug Eluting Stent
5/21/2013 7:15:53 AM
More...
|
Abbott Vascular (ABT) Cuts Another 450 Jobs
2/22/2013 7:53:56 AM
More...
|
Abbott Vascular (ABT) Wins FDA Approval for Heart Stent
1/3/2013 7:39:31 AM
More...
|
Abbott Vascular (ABT)'s AbbVie Officially Launches With Creation of 175 Jobs, Patients
1/2/2013 7:37:49 AM
More...
|
Abbott Vascular (ABT) XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
5/15/2012 7:02:31 AM
More...
|
Abbott Vascular (ABT)'s Self-Expanding and Balloon-Expandable Stent Systems Perform Well in Study of Real-World Peripheral Artery Disease Patients
5/11/2012 10:07:26 AM
More...
|
Abbott Vascular (ABT) and St. Jude Medical (STJ) Broaden Alliance for Cardiovascular Products in the United States
4/23/2012 10:00:50 AM
More...
|
Abbott Vascular (ABT) Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan
4/9/2012 7:45:19 AM
More...
|
New Data Reinforce Clinical Performance of Abbott Vascular (ABT)'s ABSORB Bioresorbable Vascular Scaffold
11/14/2011 2:13:22 PM
More...
|
Abbott Vascular (ABT) to Present New Data for Key Vascular Products at TCT 2011
11/3/2011 11:19:08 AM
More...
|
|